1.
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING...
by Cahn, Pedro, Dr
The Lancet (British edition), 2013, Vol.382 (9893), p.700-708

2.
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
by Turpie, Alexander GG, MD
The Lancet (British edition), 2009, Vol.373 (9676), p.1673-1680

3.
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected...
by Molina, Jean-Michel, Prof
The Lancet (British edition), 2008, Vol.372 (9639), p.646-655

4.
A prospective social and molecular investigation of gonococcal transmission
by Ward, Helen
The Lancet (British edition), 2000, Vol.356 (9244), p.1812-1817

5.
Diagnosis of deep-vein thrombosis: comparison of clinical evaluation, ultrasound, plethysmography, and venoscan with X-ray venogram
by Sandler, D A
The Lancet (British edition), 1984-09-29, Vol.2 (8405), p.716-719
